Axogen Inc (FRA:LT3)
€ 6.25 -0.25 (-3.85%) Market Cap: 285.76 Mil Enterprise Value: 333.88 Mil PE Ratio: 0 PB Ratio: 3.19 GF Score: 63/100

AxoGen Inc Annual Shareholders Meeting Transcript

Aug 14, 2019 / 08:00PM GMT
Release Date Price: €13.43 (-4.14%)
Karen Zaderej
AxoGen, Inc. - Chairman, President & CEO

My name is Karen Zaderej, and I'm the Chairman of the AxoGen Board of Directors and the Chief Executive Officer. We're going to start today with some introduction, followed by a formal portion of the meeting and then a company update. After the update, we look forward to answering any questions you may have.

First, I'd like to introduce AxoGen Inc.'s current directors and thank them for their service to the company and the opportunity they've provided for AxoGen to move forward and continue in its growth and success.

I'd like to start with Jamie Grooms, company founder. I'd like to personally thank Jamie for all of his vision, drive and his personal partnership with me in helping to drive our overall start of the company and success.

Dr. Mark Gold, who's also Chairman of the Governance and Nominating Committee of the Board of Directors. The Governance and Nominating Committee provides oversight in relation to the corporate governance of AxoGen. In addition, it continually assesses the capabilities and needs of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot